prednisolone has been researched along with Graves Ophthalmopathy in 22 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this observational study, we intended to examine whether the use of high doses of radioiodine (RAI) [22 mCi (814 MBq)] with prophylaxis of oral glucocorticoids (oGCS) does not exacerbate Graves ophthalmopathy (GO) in smokers and non-smokers, especially regards to the urine level cotinine and ocular changes before and after RIT." | 7.79 | The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy. ( Budny, B; Czarnywojtek, A; Florek, E; Komar-Rychlicka, K; Kurdybacha, P; Miechowicz, I; Ruchala, M; Szczepanek, E; Waligorska-Stachura, J; Wasko, R; Zgorzalewicz-Stachowiak, M, 2013) |
| "A 55-year-old woman with concurrent active thyroid orbitopathy and B-cell lymphoma developed acute exacerbation of thyroid orbitopathy after receiving Rituximab, cyclophosphamide, hydroxydaunorubicin, Prednisone (R-CHOP) chemotherapy, presenting with subtotal loss of vision and severe eyelid edema." | 3.88 | Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma. ( Croon-de Boer, F; Dalm, VASH; Liu, C; Paridaens, D; van Hagen, PM, 2018) |
| " In this observational study, we intended to examine whether the use of high doses of radioiodine (RAI) [22 mCi (814 MBq)] with prophylaxis of oral glucocorticoids (oGCS) does not exacerbate Graves ophthalmopathy (GO) in smokers and non-smokers, especially regards to the urine level cotinine and ocular changes before and after RIT." | 3.79 | The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy. ( Budny, B; Czarnywojtek, A; Florek, E; Komar-Rychlicka, K; Kurdybacha, P; Miechowicz, I; Ruchala, M; Szczepanek, E; Waligorska-Stachura, J; Wasko, R; Zgorzalewicz-Stachowiak, M, 2013) |
| "To measure the 8-hydroxy-2'-deoxyguanosine (8-OHdG) level in patients having active Graves ophthalmopathy (GO) and to compare this oxidative stress biomarker and the clinical evolution of patients after systemic corticosteroid treatment." | 3.74 | Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy. ( Cheng, CY; Hsu, WM; Kao, SC; Kau, HC; Lee, CF; Tsai, CC; Wei, YH, 2007) |
| " We concluded that orbital MR imaging combined with CAS could improve the sensitivity of detection of active disease and the prediction of the response to ivGC." | 2.75 | Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. ( Murakami, T; Nakashima, A; Noguchi, H; Noguchi, S; Noguchi, Y; Ohyabu, Y; Tachibana, S, 2010) |
| "Gaze-evoked amaurosis (GEA) describes visual loss associated with eccentric gaze that recovers when the eye is returned to primary position." | 2.52 | Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature. ( Bremner, FD; Orlans, HO, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Uzlu, D | 1 |
| Bulanık, FT | 1 |
| Erdöl, H | 1 |
| Günay, M | 1 |
| Bulanık, ÖB | 1 |
| Perepelova, MA | 1 |
| Zaitseva, EL | 1 |
| Bessmertnaya, EG | 1 |
| Grusha, YO | 1 |
| Sviridenko, NY | 1 |
| Galstyan, GR | 1 |
| Balakrishnan, N | 1 |
| Meel, R | 1 |
| Das, D | 1 |
| Detiger, SE | 1 |
| Kremer, TM | 1 |
| A S H Dalm, V | 1 |
| de Keizer, ROB | 1 |
| Wubbels, RJ | 1 |
| Metselaar, JM | 1 |
| van Hagen, PM | 2 |
| Peeters, RP | 1 |
| Paridaens, D | 2 |
| Liu, C | 1 |
| Dalm, VASH | 1 |
| Croon-de Boer, F | 1 |
| Czarnywojtek, A | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Budny, B | 1 |
| Wasko, R | 1 |
| Florek, E | 1 |
| Szczepanek, E | 1 |
| Komar-Rychlicka, K | 1 |
| Waligorska-Stachura, J | 1 |
| Kurdybacha, P | 1 |
| Miechowicz, I | 1 |
| Ruchala, M | 1 |
| Higashiyama, T | 1 |
| Nishida, Y | 1 |
| Morino, K | 1 |
| Ugi, S | 1 |
| Nishio, Y | 1 |
| Maegawa, H | 1 |
| Ohji, M | 1 |
| Watanabe, N | 1 |
| Noh, JY | 1 |
| Kozaki, A | 1 |
| Iwaku, K | 1 |
| Sekiya, K | 1 |
| Kosuga, Y | 1 |
| Matsumoto, M | 1 |
| Suzuki, M | 1 |
| Yoshihara, A | 1 |
| Ohye, H | 2 |
| Kobayashi, S | 1 |
| Kunii, Y | 1 |
| Mukasa, K | 1 |
| Sugino, K | 1 |
| Inoue, T | 1 |
| Ito, K | 1 |
| Sendhil Kumaran, M | 1 |
| Dutta, P | 1 |
| Sakia, U | 1 |
| Dogra, S | 1 |
| Orlans, HO | 1 |
| Bremner, FD | 1 |
| Lazarus, JH | 1 |
| Bartalena, L | 1 |
| Marcocci, C | 1 |
| Kahaly, GJ | 1 |
| Krassas, G | 1 |
| Wiersinga, WM | 1 |
| Alkawas, AA | 1 |
| Hussein, AM | 1 |
| Shahien, EA | 1 |
| Tachibana, S | 1 |
| Murakami, T | 1 |
| Noguchi, H | 1 |
| Noguchi, Y | 1 |
| Nakashima, A | 1 |
| Ohyabu, Y | 1 |
| Noguchi, S | 1 |
| Rajendram, R | 1 |
| Bunce, C | 1 |
| Lee, RW | 1 |
| Morley, AM | 1 |
| Tsai, CC | 2 |
| Kau, HC | 2 |
| Tsai, HH | 1 |
| Kao, SC | 2 |
| Hsu, WM | 2 |
| Ng, CM | 1 |
| Yuen, HK | 1 |
| Choi, KL | 1 |
| Chan, MK | 1 |
| Yuen, KT | 1 |
| Ng, YW | 1 |
| Tiu, SC | 1 |
| Kubota, S | 1 |
| Nishihara, E | 1 |
| Kudo, T | 1 |
| Ito, M | 1 |
| Fukata, S | 1 |
| Amino, N | 1 |
| Kuma, K | 1 |
| Miyauchi, A | 1 |
| Salvatore, D | 1 |
| Fenzi, G | 1 |
| Meyer, PA | 1 |
| Hiromatsu, Y | 1 |
| Cheng, CY | 1 |
| Lee, CF | 1 |
| Wei, YH | 1 |
| Acharya, SH | 1 |
| Avenell, A | 1 |
| Philip, S | 1 |
| Burr, J | 1 |
| Bevan, JS | 1 |
| Abraham, P | 1 |
5 reviews available for prednisolone and Graves Ophthalmopathy
| Article | Year |
|---|---|
Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature.
Topics: Administration, Oral; Blindness; Fixation, Ocular; Glucocorticoids; Graves Ophthalmopathy; Humans; M | 2015 |
Orbital radiotherapy for adult thyroid eye disease.
Topics: Adult; Anti-Inflammatory Agents; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Pr | 2012 |
Avoiding surgery for thyroid eye disease.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Ophthalmopat | 2006 |
[Steroid therapy for Graves' ophthalmopathy].
Topics: Administration, Oral; Combined Modality Therapy; Drug Administration Schedule; Graves Ophthalmopathy | 2006 |
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
Topics: Antithyroid Agents; Graves Disease; Graves Ophthalmopathy; Humans; Iodine Radioisotopes; Prednisolon | 2008 |
7 trials available for prednisolone and Graves Ophthalmopathy
| Article | Year |
|---|---|
Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study.
Topics: Adult; Aged; Chemoprevention; Disease Progression; Female; Graves Disease; Graves Ophthalmopathy; Hu | 2015 |
Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Exophthalmos; Eye Movements; Female; Glucocor | 2010 |
Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.
Topics: Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Early Diagnosis; Female; Glucoco | 2010 |
Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Eye; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Inje | 2006 |
Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Topics: Administration, Oral; Analysis of Variance; Chi-Square Distribution; Combined Modality Therapy; Doub | 2005 |
Effect of high dose methylprednisolone pulse therapy followed by oral prednisolone administration on the production of anti-TSH receptor antibodies and clinical outcome in Graves' disease.
Topics: Administration, Oral; Adult; Autoantibodies; Case-Control Studies; Female; Graves Disease; Graves Op | 2005 |
Avoiding surgery for thyroid eye disease.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Ophthalmopat | 2006 |
11 other studies available for prednisolone and Graves Ophthalmopathy
| Article | Year |
|---|---|
An evaluation of corneal endothelial cell morphology in patients with thyroid-associated ophthalmopathy.
Topics: Cell Count; Endothelial Cells; Endothelium, Corneal; Female; Graves Ophthalmopathy; Humans; Male; Pr | 2023 |
[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Myxedema; Patients; Prednisolone | 2023 |
Case of IgG4 orbitopathy's remarkable response to oral corticosteroid therapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Diagnosis, Differential; Graves Ophthalmopathy; Human | 2020 |
A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposure.
Topics: Adult; Aged; Drug Implants; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Human | 2021 |
Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma.
Topics: Administration, Oral; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy P | 2018 |
The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy.
Topics: Adult; Chemoradiotherapy; Cotinine; Dose-Response Relationship, Radiation; Female; Glucocorticoids; | 2013 |
Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Diplopia; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; | 2015 |
Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Clobetasol; Drug Therapy, Combination; | 2015 |
Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association.
Topics: Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Hyperthyroidism; Iodine Radioisotope | 2010 |
Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Topics: Adult; Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Iodine Radioisotopes; Middle | 2006 |
Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Adult; Biomarkers; Deoxyguanosine; Enzyme-Linked | 2007 |